Mitchel Sayare, Chief Executive Officer at IMMUNOGEN INC (IMGN), sold 40,800 shares at $4.87 ($197K) on 2007-11-27, disclosed to the SEC on 2007-11-29.
Open-market sale of $197k IMGN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.78 | 300 | $1K | 0.7% |
| 2 | $4.79 | 800 | $4K | 1.9% |
| 3 | $4.80 | 1,261 | $6K | 3.1% |
| 4 | $4.81 | 1,100 | $5K | 2.7% |
| 5 | $4.82 | 1,300 | $6K | 3.2% |
| 6 | $4.83 | 2,039 |
| $10K |
| 5.0% |
| 7 | $4.84 | 1,700 | $8K | 4.2% |
| 8 | $4.85 | 300 | $1K | 0.7% |
| 9 | $4.86 | 1,800 | $9K | 4.4% |
| 10 | $4.87 | 400 | $2K | 1.0% |
| 11 | $4.88 | 200 | $976 | 0.5% |
| 12 | $4.89 | 300 | $1K | 0.7% |
| 13 | $4.77 | 128 | $611 | 0.3% |
| 14 | $4.78 | 372 | $2K | 0.9% |
| 15 | $4.79 | 100 | $479 | 0.2% |
| 16 | $4.80 | 4,051 | $19K | 9.9% |
| 17 | $4.81 | 1,100 | $5K | 2.7% |
| 18 | $4.82 | 2,200 | $11K | 5.4% |
| 19 | $4.83 | 9,682 | $47K | 23.7% |
| 20 | $4.84 | 3,907 | $19K | 9.6% |
| 21 | $4.85 | 2,000 | $10K | 4.9% |
| 22 | $4.85 | 3,786 | $18K | 9.3% |
| 23 | $4.86 | 609 | $3K | 1.5% |
| 24 | $4.87 | 200 | $974 | 0.5% |
| 25 | $4.88 | 244 | $1K | 0.6% |
| 26 | $4.90 | 121 | $593 | 0.3% |
| 27 | $4.92 | 800 | $4K | 2.0% |
| Total | $4.83 avg | 40,800 | $197K | 100% |
| Filing → |
| IMGN | SELL | 2011-08-01 | $133K | — | Filing → |
| IMGN | SELL | 2011-07-18 | $150K | — | Filing → |
| IMGN | SELL | 2011-06-27 | $117K | — | Filing → |